MET
58
-2
CMCSA
39
7
AIG
53
-3
PLD
45
-3
WY
45
6
TRIP
57
-3
WM
50
-4
QRVO
53
-2
STI
11
-4
IVZ
69
7
V
36
-8
VFC
72
-7
IP
34
-5
BRK.B
40
-3
NWSA
62
-4
BEN
46
-2
SO
50
-3
EIX
45
-8
NWL
54
-3
L
60
-4
MET
58
-2
CMCSA
39
7
AIG
53
-3
PLD
45
-3
WY
45
6
TRIP
57
-3
WM
50
-4
QRVO
53
-2
STI
11
-4
IVZ
69
7
V
36
-8
VFC
72
-7
IP
34
-5
BRK.B
40
-3
NWSA
62
-4
BEN
46
-2
SO
50
-3
EIX
45
-8
NWL
54
-3
L
60
-4
Financhill
Back

Sylvania Platinum Ltd. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
49

SAPLF
Sylvania Platinum Ltd.

Last Price:
$1.22
Seasonality Move:
3.85%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
49
Sylvania Platinum Ltd. (SAPLF) is a Sell

Is Sylvania Platinum Ltd. a Buy, Sell or Hold?

  • The current Sylvania Platinum Ltd. [SAPLF] share price is $1.22. The Score for SAPLF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SAPLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

SAPLF Stock Price Chart

What is Sylvania Platinum Ltd.'s stock price today?

  • The Sylvania Platinum Ltd. share price today is $1.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAPLF is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

SAPLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 58.91 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.09 - 1.19) Buy
Bollinger Bands (100): (1.02 - 1.2) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

SAPLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.19 Buy
20-day SMA: 1.15 Buy
50-day SMA: 1.18 Buy
200-day SMA: 0.93 Buy
8-day EMA: 1.2 Buy
20-day EMA: 1.17 Buy
50-day EMA: 1.15 Buy
200-day EMA: 0.99 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Sylvania Platinum Ltd. Earnings Growth & SAPLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Sylvania Platinum Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):